Thu, 17th Dec 2020 15:21
RIO DE JANEIRO, Dec 17 (Reuters) - Pfizer has not yet
applied for emergency use of its COVID-19 vaccine in Brazil,
health regulator Anvisa said on Thursday, adding that the
company has not yet provided enough data for the vaccine to be
used locally.
Anvisa added in its statement that no vaccine producer has
yet applied for a definitive registration or for emergency use
of a COVID-19 vaccine in Brazil.
(Reporting by Gabriel Stargardter
Editing by Brad Haynes)
(Correcting company name in headline)
(Alliance News) - Shares in Angle PLC jumped on Friday, after the company said it has been chosen to develop a prostate cancer assay using its Parsort...
(Alliance News) - London's FTSE 100 is called to open higher on Friday, on the expectation of a softer US jobs report, which could take some sting out...
(Alliance News) - AstraZeneca PLC on Thursday said it observed positive high-level results in the Echo phase 3 trial of its Calquence treatment for pr...
(Sharecast News) - AstraZeneca has reported positive results from the use of its Calquence drug in a clinical trial to treat a rare type of blood canc...
Astrazeneca (AZN)